Fludrace® 62.5 microgram
- Product
Fludrace 62,5 microgram, tablets with breakline
- Authorisation
NL-RVG 50721
- Active ingredient
Fludrocortisone acetate
- Indication
Supplementation for primary adrenal insufficiency (Addison’s disease) and congenital adrenal cortex hyperplasia (adrenogenital syndrome)
- Storage condition
Below 25 °C
Fludrocortisone is used as a supplement in primary adrenal insufficiency (Addison’s disease) and in congenital adrenal hyperplasia (adrenogenital syndrome), in addition to glucocorticoid therapy.
The tablets can be divided into equal doses thus a dose of 31.25 micrograms can also be achieved.
Legal status
In the Netherlands, Fludrace is distributed to (hospital)pharmacies by the pharmaceutical wholesalers.
When this medicine is supplied outside the Netherlands, it is considered to be an unlicensed medicine in the country of the recipient.
Availability for (Hospital) Pharmacies
(Hospital) Pharmacies outside the Netherlands that would like to know more about the availability of this product are welcome to contact us via our contact form.
